01P — Medpace Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- €11.13bn
- €10.70bn
- $2.53bn
Annual cashflow statement for Medpace Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 182 | 245 | 283 | 404 | 451 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 30.8 | 37.3 | 42.9 | 44.6 | 56.9 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 66.7 | 106 | 106 | 157 | 96.3 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | 263 | 388 | 433 | 609 | 713 |
| Capital Expenditures | -28.3 | -36.9 | -36.6 | -36.5 | -31.4 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -3.09 | -1.86 | 2.02 | 8.24 | 0.216 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -31.4 | -38.7 | -34.6 | -28.3 | -31.1 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -44.5 | -776 | -183 | -154 | -860 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 184 | -433 | 217 | 424 | -172 |